Evaluation of preoperative serum markers for individual patient prognosis in stage I–III rectal cancer

Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut)

(2013) Dominik P. Modest et al.   ANTI-CANCER DRUGS

Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy

(2013) S K M Spencer et al.   BRITISH JOURNAL OF CANCER

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer

(2013) M Stotz et al.   BRITISH JOURNAL OF CANCER

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

(2013) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

Circulating Inflammation Markers and Prospective Risk for Lung Cancer

(2013) Meredith S. Shiels et al.   JNCI-Journal of the National Cancer Institute

Evaluation of predictive markers for patients with advanced colorectal cancer

(2012) Per Byström et al.   ACTA ONCOLOGICA

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

(2012) H. J. Schmoll et al.   ANNALS OF ONCOLOGY

Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers

(2012) Adetunji T. Toriola et al.   INTERNATIONAL JOURNAL OF CANCER

Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment

(2010) E. Van Cutsem et al.   ANNALS OF ONCOLOGY

Clinical significance of tumor markers and an emerging perspective on colorectal cancer

(2008) Keishi Yamashita et al.   CANCER SCIENCE

Serum amyloid A: An acute-phase protein involved in tumour pathogenesis

(2008) E. Malle et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Prognostic factors in survival of colorectal cancer patients after surgery

(2008) F. Mehrkhani et al.   Colorectal Disease

Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer

(2008) Kimmie Ng et al.   JOURNAL OF CLINICAL ONCOLOGY